Literature DB >> 16081144

Accuracy of coding for possible warfarin complications in hospital discharge abstracts.

T Arnason1, P S Wells, C van Walraven, A J Forster.   

Abstract

BACKGROUND: Hospital discharge abstracts could be used to identify complications of warfarin if coding for bleeding and thromboembolic events are accurate.
OBJECTIVES: To measure the accuracy of International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9CM) codes for bleeding and thromboembolic diagnoses.
SETTING: University affiliated, tertiary care hospital in Ottawa, Canada. PATIENTS: A random sample of patients discharged between September 1999 and September 2000 with an ICD-9-CM code indicating a bleeding or thromboembolic diagnosis.
METHODS: Gold-standard coding was determined by a trained chart abstractor using explicit standard diagnostic criteria for bleeding, major bleeding, and acute thromboembolism. The abstractor was blinded to the original coding. We calculated the sensitivity, specificity, positive, and negative predictive values of the original ICD-9CM codes for bleeding or thromboembolism diagnoses.
RESULTS: We reviewed 616 medical records. 361 patients (59%) had a code indicating a bleeding diagnosis, 291 patients (47%) had a code indicating a thromboembolic diagnosis and 36 patients (6%) had a code indicating both. According to the gold standard criteria, 352 patients experienced bleeding, 333 experienced major bleeding, and 188 experienced an acute thromboembolism. For bleeding, the ICD-9CM codes had the following sensitivity, specificity, positive and negative predictive values [95% CI]: 93% [90-96], 88% [83-91], 91% [88-94], and 91% [87-94], respectively. For major bleeding, the ICD-9CM codes had the following sensitivity, specificity, positive and negative predictive values: 94% [91-96], 83% [78-87], 87% [83-90], and 92% [88-95], respectively. For thromboembolism, the ICD-9CM codes had the following sensitivity, specificity, positive and negative predictive values: 97% [94-99], 74% [70-79], 62% [57-68], and 98% [96-99], respectively. By selecting a sub-group of ICD-9CM codes for thromboembolism, the positive predictive value increased to 87%.
CONCLUSION: In our centre, the discharge abstract could be used to identify and exclude patients hospitalized with a major bleed or thromboembolism. If coding quality for bleeding is similar in other hospitals, these ICD-9-CM diagnostic codes could be used to study population-based warfarin-associated hemorrhagic complications using administrative databases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081144     DOI: 10.1016/j.thromres.2005.06.015

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  72 in total

1.  Serotonergic antidepressants and increased bleeding risk in patients undergoing breast biopsy.

Authors:  Artin A Mahdanian; Karl J Looper; Simon L Bacon; Benoit Mesurolle; Sarkis H Meterissian; Soham Rej
Journal:  Ther Adv Psychopharmacol       Date:  2015-12

2.  Should we regionalize the management of pulmonary embolism?

Authors:  Marc Carrier; Philip S Wells
Journal:  CMAJ       Date:  2008-01-01       Impact factor: 8.262

3.  Serious bleeding events due to warfarin and antibiotic co-prescription in a cohort of veterans.

Authors:  Michael A Lane; Angelique Zeringue; Jay R McDonald
Journal:  Am J Med       Date:  2014-03-19       Impact factor: 4.965

Review 4.  Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant.

Authors:  Michael Ganetsky; Kavita M Babu; Steven D Salhanick; Robert S Brown; Edward W Boyer
Journal:  J Med Toxicol       Date:  2011-12

5.  A population-based assessment of the drug interaction between levothyroxine and warfarin.

Authors:  D Pincus; T Gomes; C Hellings; H Zheng; J M Paterson; M M Mamdani; D N Juurlink
Journal:  Clin Pharmacol Ther       Date:  2012-10-24       Impact factor: 6.875

Review 6.  Developing a Conversation Aid to Support Shared Decision Making: Reflections on Designing Anticoagulation Choice.

Authors:  Claudia L Zeballos-Palacios; Ian G Hargraves; Peter A Noseworthy; Megan E Branda; Marleen Kunneman; Bruce Burnett; Michael R Gionfriddo; Christopher J McLeod; Haeshik Gorr; Juan Pablo Brito; Victor M Montori
Journal:  Mayo Clin Proc       Date:  2019-01-11       Impact factor: 7.616

7.  Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study.

Authors:  Sylvie Perreault; Payman Shahabi; Robert Côté; Stéphanie Dumas; Étienne Rouleau-Mailloux; Yassamin Feroz Zada; Sylvie Provost; Ian Mongrain; Marc Dorais; Thao Huynh; Simon Kouz; Ariel Diaz; Mark Blostein; Simon de Denus; Jacques Turgeon; Jeffrey Ginsberg; Jacques Lelorier; Lyne Lalonde; Lambert Busque; Jeannine Kassis; Mario Talajic; Jean-Claude Tardif; Marie-Pierre Dubé
Journal:  Clin Cardiol       Date:  2018-05-15       Impact factor: 2.882

8.  Predictive value of pediatric thrombosis diagnoses in the Danish National Patient Registry.

Authors:  Ruta Tuckuviene; Soeren Risom Kristensen; Jon Helgestad; Anette Luther Christensen; Soeren Paaske Johnsen
Journal:  Clin Epidemiol       Date:  2010-08-09       Impact factor: 4.790

9.  Medical complications in patients with stroke: data validity in a stroke registry and a hospital discharge registry.

Authors:  Annette Ingeman; Grethe Andersen; Heidi H Hundborg; Søren P Johnsen
Journal:  Clin Epidemiol       Date:  2010-08-09       Impact factor: 4.790

10.  Validity of claims-based stroke algorithms in contemporary Medicare data: reasons for geographic and racial differences in stroke (REGARDS) study linked with medicare claims.

Authors:  Hiraku Kumamaru; Suzanne E Judd; Jeffrey R Curtis; Rekha Ramachandran; N Chantelle Hardy; J David Rhodes; Monika M Safford; Brett M Kissela; George Howard; Jessica J Jalbert; Thomas G Brott; Soko Setoguchi
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.